Robin Sherrington's Form 4 filing
Xenon Pharmaceuticals Inc. (XENE) · filed Sep 2, 2022
- Accession no.
- 0001209191-22-048508
- Filed
- Sep 2, 2022
- Trade date
- Aug 31-Sep 1, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.50M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Robin SherringtonCIK 0001619962 | Officer (EVP, Strategy & Innovation) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2022 | Common Shares | MOption exerciseAcquired | +17,488 | $2.67 | +$46,692.96 | 34,720 | Direct | |
| Aug 31, 2022 | Common Shares | MOption exerciseAcquired | +5,000 | $4.75 | +$23,750 | 39,720 | Direct | |
| Aug 31, 2022 | Common Shares | FTax withholdingDisposed | −1,572 | $37.86 | −$59,515.92 | 38,148 | Direct | |
| Aug 31, 2022 | Common Shares | SSaleDisposed | −21,352 | $38.57 | −$823,546.64 | 16,796 | Direct | |
| Sep 1, 2022 | Common Shares | MOption exerciseAcquired | +50,000 | $4.75 | +$237,500 | 66,796 | Direct | |
| Sep 1, 2022 | Common Shares | FTax withholdingDisposed | −6,121 | $38.81 | −$237,556.01 | 60,675 | Direct | |
| Sep 1, 2022 | Common Shares | SSaleDisposed | −35,103 | $38.03 | −$1,334,967.09 | 25,572 | Direct | |
| Sep 1, 2022 | Common Shares | SSaleDisposed | −8,776 | $38.80 | −$340,508.8 | 16,796 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2022 | Common Shares | MOption exerciseDisposed | −17,488 | $0.00 | $0 | 0 | Direct | |
| Aug 31, 2022 | Common Shares | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 0 | Direct | |
| Sep 1, 2022 | Common Shares | MOption exerciseDisposed | −50,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.